Patent Assignment
Reel/Frame 022671/0836
Assignment of Assignor's Interest
Recorded: 2009-05-11
Pages: 3
Assignor
UMANA, PABLO
Executed: 2008-10-21
Assignee
GLYCART BIOTECHNOLOGY AG
OF WAGISTRASSE 18, A SWISS COMPANY, CH-8952 SCHLIEREN, SWITZERLAND
Covered Property
(1)
Combination Therapy of a Type Ii Anti-CD20 Antibody with an Anti-Bcl-2 Active Agent
Application:
12/234,739 →
Publication:
US 2009/0098118
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
May 11, 2009
From: FRIESS, THOMAS; KLEIN, CHRISTIAN; STREIN, PAMELA
To: F. HOFFMANN-LA ROCHE AG
Reel/Frame 022673/0066 →
Assignment of Assignor's Interest
May 11, 2009
From: F. HOFFMANN-LA ROCHE AG
To: HOFFMANN-LA ROCHE, INC.
Reel/Frame 022767/0868 →
Assignment of Assignor's Interest
May 27, 2010
From: HOFFMANN-LA ROCHE INC.
To: ROCHE GLYCART AG
Reel/Frame 024464/0418 →
Change of Name
Jun 29, 2010
From: GLYCART BIOTECHNOLOGY AG
To: ROCHE GLYCART AG
Reel/Frame 024624/0566 →